Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.261NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.261NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.3.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EP.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.4 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.4 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.420NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.420NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
XBB.2.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.39.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.39.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EK.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.233NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.233NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.215NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.215NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.82NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.82NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.462NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.462NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.218NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.218NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.462NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.462NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.147NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.147NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.6 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.6 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.5 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.5 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.19 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.19 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AM.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AM.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.15 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.15 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.113NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.113NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GA.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used